Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD
NCT03028701
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Copd
Interventions
DRUG:
Formoterol/Budesonide 12/400 mcg Discair
Sponsor
Neutec Ar-Ge San ve Tic A.Ş